EDITEditas Medicine, Inc.
- Market cap
- $368.59M
- as of 2026-10-23
- Latest close
- $2.40
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-11-09
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Ory Daniel ScottEVP, Chief Medical Officer | Sep 8 | Sep 9 | A · derivative | 950,000 | $3.03 | $2,878,500 | 950,000 | No | Form 4 |
| O'Neill Gilmore NeilCEO | Sep 3 | Sep 4 | S | 5,124 | $3.04 | Sale −$15,577 | 243,189 | Yes | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Sep 3 | Sep 4 | S | 709 | $3.04 | Sale −$2,155 | 61,660 | Yes | Form 4 |
| Parison AmySVP, Chief Financial Officer | Sep 3 | Sep 4 | S | 453 | $3.04 | Sale −$1,377 | 13,839 | Yes | Form 4 |
| Ellinor Patrick Thomas II | Aug 6 | Aug 7 | A · derivative | 103,400 | $2.90 | $299,860 | 103,400 | No | Form 4 |
| Parison AmySVP, Chief Financial Officer | Aug 3 | Aug 5 | S | 678 | $2.58 | Sale −$1,749 | 14,292 | Yes | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Jul 28 | Jul 29 | S | 4,928 | $2.67 | Sale −$13,158 | 62,369 | Yes | Form 4 |
| Levy Elliott M. | Jun 17 | Jun 22 | A · derivative | 51,700 | $2.55 | $131,835 | 51,700 | No | Form 4 |
| Scadden David | Jun 17 | Jun 22 | A · derivative | 51,700 | $2.55 | $131,835 | 51,700 | No | Form 4 |
| Hirsch Andrew | Jun 17 | Jun 22 | A · derivative | 51,700 | $2.55 | $131,835 | 51,700 | No | Form 4 |
| Hopfield Jessica | Jun 17 | Jun 22 | A · derivative | 51,700 | $2.55 | $131,835 | 51,700 | No | Form 4 |
| Connaughton Bernadette | Jun 17 | Jun 22 | A · derivative | 51,700 | $2.55 | $131,835 | 51,700 | No | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Jun 3 | Jun 5 | S | 731 | $2.70 | Sale −$1,974 | 67,297 | Yes | Form 4 |
| O'Neill Gilmore NeilCEO | Jun 3 | Jun 5 | S | 15,380 | $2.70 | Sale −$41,526 | 248,313 | Yes | Form 4 |
| Parison AmySVP, Chief Financial Officer | Jun 3 | Jun 5 | S | 464 | $2.70 | Sale −$1,253 | 14,970 | Yes | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Mar 12 | Mar 16 | A · derivative | 292,856 | $2.54 | $743,854 | 292,856 | Yes | Form 4 |
| Parison AmySVP, Chief Financial Officer | Mar 12 | Mar 16 | A · derivative | 292,856 | $2.54 | $743,854 | 292,856 | Yes | Form 4 |
| O'Neill Gilmore NeilCEO | Mar 12 | Mar 16 | A · derivative | 1,015,200 | $2.54 | $2,578,608 | 1,015,200 | Yes | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Mar 3 | Mar 4 | S | 749 | $2.02 | Sale −$1,513 | 68,028 | Yes | Form 4 |
| Parison AmySVP, Chief Financial Officer | Mar 3 | Mar 4 | S | 474 | $2.02 | Sale −$957 | 15,434 | Yes | Form 4 |
| O'Neill Gilmore NeilCEO | Mar 3 | Mar 4 | S | 5,394 | $2.02 | Sale −$10,896 | 263,693 | Yes | Form 4 |
| Parison AmySVP, Chief Financial Officer | Dec 3, 2025 | Dec 4, 2025 | S | 461 | $2.15 | Sale −$991 | 15,908 | Yes | Form 4 |
| O'Neill Gilmore NeilCEO | Dec 3, 2025 | Dec 4, 2025 | S | 5,603 | $2.15 | Sale −$12,046 | 269,087 | Yes | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Dec 3, 2025 | Dec 4, 2025 | S | 713 | $2.15 | Sale −$1,533 | 68,777 | Yes | Form 4 |
| O'Neill Gilmore NeilCEO | Sep 3, 2025 | Sep 4, 2025 | S | 5,592 | $2.60 | Sale −$14,539 | 274,690 | Yes | Form 4 |
| Parison AmySVP, Chief Financial Officer | Sep 3, 2025 | Sep 4, 2025 | S | 458 | $2.60 | Sale −$1,191 | 16,369 | Yes | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Sep 3, 2025 | Sep 4, 2025 | S | 710 | $2.60 | Sale −$1,846 | 69,490 | Yes | Form 4 |
| Parison AmySVP, Chief Financial Officer | Aug 7, 2025 | Aug 8, 2025 | S | 679 | $2.58 | Sale −$1,752 | 16,827 | Yes | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Jul 31, 2025 | Aug 4, 2025 | S | 5,121 | $2.49 | Sale −$12,751 | 64,398 | Yes | Form 4 |
| Hirsch Andrew | Jun 6, 2025 | Jun 10, 2025 | A · derivative | 37,500 | $1.91 | $71,625 | 37,500 | No | Form 4 |
| Connaughton Bernadette | Jun 6, 2025 | Jun 10, 2025 | A · derivative | 37,500 | $1.91 | $71,625 | 37,500 | No | Form 4 |
| Levy Elliott M. | Jun 6, 2025 | Jun 10, 2025 | A · derivative | 37,500 | $1.91 | $71,625 | 37,500 | No | Form 4 |
| Scadden David | Jun 6, 2025 | Jun 10, 2025 | A · derivative | 37,500 | $1.91 | $71,625 | 37,500 | No | Form 4 |
| Hopfield Jessica | Jun 6, 2025 | Jun 10, 2025 | A · derivative | 37,500 | $1.91 | $71,625 | 37,500 | No | Form 4 |
| O'Neill Gilmore NeilCEO | Jun 3, 2025 | Jun 4, 2025 | S | 15,192 | $1.72 | Sale −$26,130 | 280,282 | Yes | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Jun 3, 2025 | Jun 4, 2025 | S | 726 | $1.72 | Sale −$1,249 | 69,519 | Yes | Form 4 |
| Parison AmySVP, Chief Financial Officer | Jun 3, 2025 | Jun 4, 2025 | S | 446 | $1.72 | Sale −$767 | 17,506 | Yes | Form 4 |
| Parison AmySVP, Chief Financial Officer | Apr 8, 2025 | Apr 8, 2025 | A · derivative | 34,672 | $0.98 | $33,979 | 34,672 | No | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Mar 8, 2025 | Mar 27, 2025 | A · derivative | 275,100 | $1.72 | $473,172 | 275,100 | No | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Mar 8, 2025 | Mar 27, 2025 | A · derivative | 70,000 | $1.72 | $120,400 | 70,000 | No | Form 4 |
| O'Neill Gilmore NeilCEO | Mar 8, 2025 | Mar 27, 2025 | A · derivative | 828,000 | $1.72 | $1,424,160 | 828,000 | No | Form 4 |
| O'Neill Gilmore NeilCEO | Mar 8, 2025 | Mar 27, 2025 | A · derivative | 175,000 | $1.72 | $301,000 | 175,000 | No | Form 4 |
| Lucera ErickEVP, CHIEF FINANCIAL OFFICER | Mar 8, 2025 | Mar 27, 2025 | A · derivative | 275,100 | $1.72 | $473,172 | 275,100 | No | Form 4 |
| Lucera ErickEVP, CHIEF FINANCIAL OFFICER | Mar 8, 2025 | Mar 27, 2025 | A · derivative | 70,000 | $1.72 | $120,400 | 70,000 | No | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Mar 4, 2025 | Mar 5, 2025 | S | 2,891 | $1.71 | Sale −$4,944 | 70,245 | Yes | Form 4 |
| O'Neill Gilmore NeilCEO | Mar 4, 2025 | Mar 5, 2025 | S | 16,632 | $1.71 | Sale −$28,441 | 295,474 | Yes | Form 4 |
| Lucera ErickEVP, CHIEF FINANCIAL OFFICER | Mar 4, 2025 | Mar 5, 2025 | S | 4,109 | $1.71 | Sale −$7,026 | 112,720 | Yes | Form 4 |
| Mei BaisongEVP, CHIEF MEDICAL OFFICER | Dec 3, 2024 | Dec 5, 2024 | S | 541 | $2.08 | Sale −$1,125 | 133,354 | Yes | Form 4 |
| O'Neill Gilmore NeilCEO | Dec 3, 2024 | Dec 5, 2024 | S | 1,618 | $2.08 | Sale −$3,365 | 312,106 | Yes | Form 4 |
| O'Neill Gilmore NeilCEO | Sep 4, 2024 | Sep 6, 2024 | S | 1,555 | $3.42 | Sale −$5,318 | 313,724 | Yes | Form 4 |
| Mei BaisongEVP, CHIEF MEDICAL OFFICER | Sep 4, 2024 | Sep 6, 2024 | S | 518 | $3.42 | Sale −$1,772 | 133,895 | Yes | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Jul 25, 2024 | Jul 26, 2024 | S | 11,886 | $5.42 | Sale −$64,422 | 73,136 | Yes | Form 4 |
| Mei BaisongEVP, CHIEF MEDICAL OFFICER | Jul 19, 2024 | Jul 22, 2024 | S | 6,619 | $5.21 | Sale −$34,485 | 134,413 | Yes | Form 4 |
| Mei BaisongEVP, CHIEF MEDICAL OFFICER | Jun 4, 2024 | Jun 6, 2024 | S | 511 | $5.50 | Sale −$2,811 | 141,032 | Yes | Form 4 |
| O'Neill Gilmore NeilCEO | Jun 4, 2024 | Jun 6, 2024 | S | 12,191 | $5.50 | Sale −$67,051 | 315,279 | Yes | Form 4 |
| Vaishnaw Akshay | May 30, 2024 | Jun 3, 2024 | A · derivative | 25,000 | $5.17 | $129,250 | 25,000 | No | Form 4 |
| Connaughton Bernadette | May 30, 2024 | Jun 3, 2024 | A · derivative | 25,000 | $5.17 | $129,250 | 25,000 | No | Form 4 |
| Levy Elliott M. | May 30, 2024 | Jun 3, 2024 | A · derivative | 25,000 | $5.17 | $129,250 | 25,000 | No | Form 4 |
| Reeve Emma | May 30, 2024 | Jun 3, 2024 | A · derivative | 25,000 | $5.17 | $129,250 | 25,000 | No | Form 4 |
| Hirsch Andrew | May 30, 2024 | Jun 3, 2024 | A · derivative | 25,000 | $5.17 | $129,250 | 25,000 | No | Form 4 |
| Chatterjee Meeta | May 30, 2024 | Jun 3, 2024 | A · derivative | 25,000 | $5.17 | $129,250 | 25,000 | No | Form 4 |
| Hopfield Jessica | May 30, 2024 | Jun 3, 2024 | A · derivative | 25,000 | $5.17 | $129,250 | 25,000 | No | Form 4 |
| Scadden David | May 30, 2024 | Jun 3, 2024 | A · derivative | 25,000 | $5.17 | $129,250 | 25,000 | No | Form 4 |
| Lucera ErickEVP, CHIEF FINANCIAL OFFICER | May 20, 2024 | May 22, 2024 | S | 22,337 | $5.61 | Sale −$125,311 | 116,829 | Yes | Form 4 |
| Hopfield Jessica | May 13, 2024 | May 14, 2024 | P | 45,000 | $5.64 | Purchase +$253,800 | 67,700 | No | Form 4 |
| O'Neill Gilmore NeilCEO | Mar 5, 2024 | Mar 5, 2024 | S | 77,824 | $9.42 | Sale −$733,102 | 327,470 | Yes | Form 4 |
| Mei BaisongSVP, CHIEF MEDICAL OFFICER | Mar 4, 2024 | Mar 5, 2024 | S | 20,327 | $9.42 | Sale −$191,480 | 141,543 | Yes | Form 4 |
| Mei BaisongSVP, CHIEF MEDICAL OFFICER | Mar 2, 2024 | Mar 5, 2024 | A | 50,900 | $0.00 | $0 | 122,955 | Yes | Form 4 |
| Mei BaisongSVP, CHIEF MEDICAL OFFICER | Mar 2, 2024 | Mar 5, 2024 | A | 19,458 | $0.00 | $0 | 142,413 | Yes | Form 4 |
| Mei BaisongSVP, CHIEF MEDICAL OFFICER | Mar 2, 2024 | Mar 5, 2024 | A | 19,457 | $0.00 | $0 | 161,870 | Yes | Form 4 |
| Mei BaisongSVP, CHIEF MEDICAL OFFICER | Mar 2, 2024 | Mar 5, 2024 | A · derivative | 152,800 | $10.53 | $1,608,984 | 152,800 | Yes | Form 4 |
| O'Neill Gilmore NeilCEO | Mar 2, 2024 | Mar 5, 2024 | A | 130,700 | $0.00 | $0 | 260,869 | Yes | Form 4 |
| O'Neill Gilmore NeilCEO | Mar 2, 2024 | Mar 5, 2024 | A | 72,213 | $0.00 | $0 | 333,082 | Yes | Form 4 |
| O'Neill Gilmore NeilCEO | Mar 2, 2024 | Mar 5, 2024 | A | 72,212 | $0.00 | $0 | 405,294 | Yes | Form 4 |
| O'Neill Gilmore NeilCEO | Mar 2, 2024 | Mar 5, 2024 | A · derivative | 392,100 | $10.53 | $4,128,813 | 392,100 | Yes | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Mar 2, 2024 | Mar 5, 2024 | A | 24,800 | $0.00 | $0 | 69,967 | No | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Mar 2, 2024 | Mar 5, 2024 | A | 15,055 | $0.00 | $0 | 85,022 | No | Form 4 |
| Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER | Mar 2, 2024 | Mar 5, 2024 | A · derivative | 74,400 | $10.53 | $783,432 | 74,400 | No | Form 4 |
| Lucera ErickEVP, CHIEF FINANCIAL OFFICER | Mar 2, 2024 | Mar 5, 2024 | A | 35,300 | $0.00 | $0 | 113,200 | No | Form 4 |
| Lucera ErickEVP, CHIEF FINANCIAL OFFICER | Mar 2, 2024 | Mar 5, 2024 | A | 25,966 | $0.00 | $0 | 139,166 | No | Form 4 |
| Lucera ErickEVP, CHIEF FINANCIAL OFFICER | Mar 2, 2024 | Mar 5, 2024 | A · derivative | 106,000 | $10.53 | $1,116,180 | 106,000 | No | Form 4 |
| Eaton BruceEVP, CBO AND CTO | Dec 5, 2023 | Dec 7, 2023 | S | 103 | $10.90 | Sale −$1,123 | 74,791 | Yes | Form 4 |
| Eaton BruceEVP, CBO AND CTO | Nov 14, 2023 | Nov 16, 2023 | S | 695 | $8.21 | Sale −$5,706 | 74,894 | Yes | Form 4 |
| Eaton BruceEVP, CBO AND CTO | Nov 7, 2023 | Nov 9, 2023 | S | 139 | $8.40 | Sale −$1,168 | 75,589 | Yes | Form 4 |